Claudia Leggett
Family · Statesville, NCNPI 1831777846
Payments from drug & device makers
Across 102 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$672
- Novo Nordisk$295
- AbbVie$202
- Otsuka America Pharmaceutical, Inc.$195
- Lilly USA, LLC$128
- Exact Sciences$58
- plus $339 from 14 others
What the payments were for
- Food & beverage$1,889100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 32 | $672 |
| Novo Nordisk | 17 | $295 |
| AbbVie | 12 | $202 |
| Otsuka America Pharmaceutical, Inc. | 10 | $195 |
| Lilly USA, LLC | 8 | $128 |
| Exact Sciences | 3 | $58 |
| AstraZeneca | 3 | $52 |
| GSK | 3 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Amgen | 2 | $27 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Bayer | 1 | $18 |
| Organon | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Pfizer | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Almatica Pharma LLC | 1 | $12 |
How this compares
$1,889 in reported general payments places this provider in the 80th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 52 | $73,981 |
| EliquisApixaban | 41 | $43,776 |
| LinzessLinaclotide | 22 | $16,389 |
| MounjaroTirzepatide | 16 | $16,137 |
| JardianceEmpagliflozin | 12 | $12,698 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,303 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 32 | $4,471 |
| Novolog FlexpenInsulin Aspart | 14 | $4,394 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 80 | $2,104 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $1,684 |
| Gabapentin | 93 | $1,582 |
| Omeprazole | 81 | $1,421 |
| Celecoxib | 42 | $1,262 |
| Levothyroxine Sodium | 121 | $1,125 |
| Cyclobenzaprine Hcl | 76 | $996 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $295 | $73,98152 claims |
| PfizerEliquis | $15 | $43,77641 claims |
| AbbVieLinzess | $202 | $16,38922 claims |
| Lilly USA, LLCMounjaro | $128 | $16,13716 claims |
| Boehringer IngelheimJardiance | $14 | $12,69812 claims |
| AstraZenecaBreztri Aerosphere | $52 | $7,30312 claims |
| Almatica Pharma LLCSertraline Hcl | $12 | $27945 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,522 family providers in North Carolina.
Other family in Statesville
- Kimberly WoodsStatesville$62K
- Deborah DaywaltStatesville$13K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.